Calian Group (TSE:CGY) Releases Earnings Results

Calian Group (TSE:CGY) posted its earnings results on Thursday. The company reported C$1.10 earnings per share for the quarter, FiscalAI reports. The company had revenue of C$230.40 million during the quarter. Calian Group had a net margin of 3.97% and a return on equity of 10.35%.

Here are the key takeaways from Calian Group’s conference call:

• Record Q3 performance: Revenue rose 20% year over year to CAD 230 million, including 16% organic growth, while adjusted EBITDA increased 35% to CAD 26 million and margins expanded to 11.1%.
• Defense and space remained the primary growth engine, with revenue up 20% and adjusted EBITDA up 25%; Calian also secured a 15-year Raytheon UK agreement worth nearly CAD 300 million in base revenue, with potentially comparable variable revenue.
• Calian’s pro forma backlog is approaching CAD 1.6 billion, including approximately CAD 1.3 billion in defense, supporting management’s expectation for a second consecutive year of bookings above CAD 1 billion and continued long-term demand from defense, nuclear, and health markets.
• Essential Industries gained momentum, with revenue up 20% and adjusted EBITDA up 46%; management highlighted improving U.S. commercial and nuclear demand, as well as potential long-term benefits from Canadian recruitment initiatives and plans for new nuclear reactors.
• Management expects working-capital usage of CAD 15 million–CAD 17 million for fiscal 2026, while investments in Europe, Canada, product platforms, and efficiency initiatives will accelerate in Q4 and fiscal 2027; these investments may temporarily pressure cash flow and margins despite the stronger outlook.

Calian Group Price Performance

CGY stock opened at C$83.88 on Friday. The stock has a market cap of C$965.63 million, a PE ratio of 29.43, a P/E/G ratio of 2.50 and a beta of 0.96. Calian Group has a 12 month low of C$44.89 and a 12 month high of C$95.50. The company has a 50-day moving average price of C$81.54 and a 200 day moving average price of C$77.44. The company has a current ratio of 1.51, a quick ratio of 1.20 and a debt-to-equity ratio of 63.54.

Calian Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 9th. Stockholders of record on Wednesday, September 9th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, August 26th. Calian Group’s dividend payout ratio (DPR) is 39.30%.

Insider Transactions at Calian Group

In other Calian Group news, insider Patrick Belanger Houston sold 6,432 shares of the business’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of C$80.91, for a total transaction of C$520,413.12. Following the completion of the transaction, the insider owned 22,266 shares in the company, valued at C$1,801,542.06. The trade was a 22.41% decrease in their ownership of the stock. 0.63% of the stock is currently owned by insiders.

Calian Group News Roundup

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Analysts raised their estimates: Canadian Imperial Bank of Commerce increased its price target from C$93 to C$107, implying approximately 28.8% upside, which reinforces a constructive view of Calian Group (CGY). BayStreet.CA analyst ratings
• Positive Sentiment: Royal Bank of Canada raised its target from C$90 to C$105 and assigned an “outperform” rating, representing roughly 26.4% potential upside. BayStreet.CA analyst ratings
• Positive Sentiment: Ventum Financial upgraded its outlook, lifting its target from C$100 to C$106 and assigning a “buy” rating. The new target indicates approximately 27.6% upside. BayStreet.CA analyst ratings
• Positive Sentiment: Desjardins raised its price target from C$104 to C$109 and maintained a “buy” view, the most bullish target among the reported revisions and approximately 31.2% above the reference price. BayStreet.CA analyst ratings
• Neutral Sentiment: Calian reported record third-quarter fiscal 2026 results, including C$230.4 million in revenue and C$1.10 in earnings per share. Return on equity was 10.35%, while net margin was 3.97%. The results support the company’s growth narrative, but the available reports do not indicate how EPS compared with analyst expectations. Calian reports record third-quarter results
• Negative Sentiment: The immediate trading response was weak: shares declined on volume well above average, indicating that investors may have been disappointed by details not captured in the headline results or may be taking profits after the stock’s strong run toward its 52-week high. The specific reason for the decline was not confirmed in the reports.

Analysts Set New Price Targets

CGY has been the subject of a number of research analyst reports. Desjardins raised their price objective on Calian Group from C$104.00 to C$109.00 and gave the company a “buy” rating in a research report on Friday. Canaccord Genuity Group boosted their target price on Calian Group from C$103.00 to C$105.00 and gave the stock a “buy” rating in a research report on Monday, June 29th. Ventum Financial increased their price target on Calian Group from C$100.00 to C$106.00 and gave the company a “buy” rating in a research note on Friday. Stifel Nicolaus set a C$100.00 price objective on Calian Group and gave the stock a “buy” rating in a research note on Wednesday, May 20th. Finally, Royal Bank Of Canada upped their price objective on Calian Group from C$90.00 to C$105.00 and gave the stock an “outperform” rating in a report on Friday. Nine investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of C$101.72.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.